Product: Opdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11
Reason for recall: Lack of Assurance of Sterility.
Recall initiated: 20251021
Status: Ongoing
Classification: Class II
Recall type: Voluntary: Firm initiated